Dr. Azar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit St
Boston, MA 02114- Is this information wrong?
Summary
- Dr. Sharl Azar is a hematologist in Boston, MA at the Massachusetts General Hospital and Harvard Medical School where he serves as the Director of the Comprehensive Sickle Cell Disease Treatment Center and the inaugural Robert K. Kraft Chair in Diversity, Equity, and Inclusion. He received his medical degree from Oregon Health and Science University School of Medicine where he also completed his residency and fellowship before completing a second fellowship in hemostasis and thrombosis at the University of California, San Diego.
Education & Training
- Oregon Health & Science UniversityFellowship, Hematology and Medical Oncology, 2013 - 2016
- Oregon Health & Science UniversityResidency, Internal Medicine, 2010 - 2013
- Oregon Health and Science University School of MedicineClass of 2010
Certifications & Licensure
- OR State Medical License 2015 - Present
- MA State Medical License 2020 - 2026
- CA State Medical License 2018 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Racial and Ethnic Disparities in Metabolic Bone Disease.Lauren Y Maldonado, Linette Bosques, Sara J Cromer, Sharl S Azar, Elaine W Yu, Sherri-Ann M Burnett-Bowie> ;Endocrinology and Metabolism Clinics of North America. 2023 Dec 1
- Case 37-2023: A 29-Year-Old Man with Sickle Cell Disease and Right Hip Pain.Simeone, F., Nussbaum, E., Azar, S., Jarolimova, J.> ;The New England Journal of Medicine. 2023 Nov 30
- 9 citationsManagement of severe factor XI deficiency in cardiac surgery: A case report and review of the literature.Sharl Azar, Ophira Salomon, Jason A. Taylor> ;Haemophilia. 2017 Aug 31
- Join now to see all
Press Mentions
- Dr. Mallika Marshall Explains Importance of Black Blood Donors for Patients with Sickle Cell DiseaseFebruary 24th, 2022
- Mass General Launches Comprehensive Center for Sickle Cell Disease TreatmentJune 4th, 2021
- FDA Approves Two New Gene Therapies for Sickle Cell Disease, a 'Functional Cure' for Many PatientsDecember 12th, 2023
- Join now to see all
Hospital Affiliations
- Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: